We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker: Dr. Mate Maus, group leader of the Aging and Cancer lab at the VHIO
Aging promotes the permissiveness of tissues to cancer, contributing thereby to the rising incidence of malignancies with aging. Chronic inflammation, fibrogenesis, and accumulation of senescent cells have all been proposed to drive the permissiveness of aged tissues to cancer. In young individuals, fibrogenesis, senescence and inflammation are part of a normal protective response to tissue injury that become exacerbated with aging. Senescent cells are a main driver of fibrogenesis through their inflammatory secretome, known as senescence-associated secretory phenotype (SASP). The mechanisms involved in fibrogenesis and in the conversion of damaged cells into senescent cells remain incompletely understood. We have recently shown that conversion of healthy tissues into fibrotic tissues and conversion of damaged cells into senescent cells are both associated with abnormal accumulation of iron. We found that iron accumulation was not just a bystander phenomenon, but a direct driver of fibrogenesis, inflammation, senescence and the SASP. We demonstrated that detection of iron by magnetic resonance imaging (MRI) is a powerful non-invasive method to assess and locate fibrotic burden. All tissues accumulate iron with aging. Our lab is currently exploring the connection between age-associated iron accumulation and the rising cancer incidence with age.
Host: Dr. Miguel Segura, Childhood Cancer and Blood Disorders group (VHIR)
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.